These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31747417)

  • 1. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    Hammad SM; Hardin JR; Wilson DA; Twal WO; Nietert PJ; Oates JC
    PLoS One; 2019; 14(11):e0224496. PubMed ID: 31747417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value.
    Hammad SM; Harden OC; Wilson DA; Twal WO; Nietert PJ; Oates JC
    Front Immunol; 2021; 12():694318. PubMed ID: 34367153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study.
    Buie JNJ; Hammad SM; Nietert PJ; Magwood G; Adams RJ; Bonilha L; Sims-Robinson C
    PLoS One; 2019; 14(5):e0216213. PubMed ID: 31067249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study.
    Checa A; Idborg H; Zandian A; Sar DG; Surowiec I; Trygg J; Svenungsson E; Jakobsson PJ; Nilsson P; Gunnarsson I; Wheelock CE
    Lupus; 2017 Sep; 26(10):1023-1033. PubMed ID: 28134039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
    Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
    Harden OC; Hammad SM
    Front Immunol; 2020; 11():586737. PubMed ID: 33101319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus.
    Barnado A; Carroll RJ; Casey C; Wheless L; Denny JC; Crofford LJ
    Arthritis Res Ther; 2018 Apr; 20(1):69. PubMed ID: 29636090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of African-American ethnicity and smoking status with total and individual damage index in systemic lupus erythematosus.
    Kallas R; Li J; Petri M
    Clin Rheumatol; 2020 Feb; 39(2):365-373. PubMed ID: 31705325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in urinary ceramides, sphingoid bases, and their phosphates among patients with kidney disease.
    Morita Y; Sakai E; Isago H; Ono Y; Yatomi Y; Kurano M
    Front Nephrol; 2024; 4():1343181. PubMed ID: 38504855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood sphingolipidomics in healthy humans: impact of sample collection methodology.
    Hammad SM; Pierce JS; Soodavar F; Smith KJ; Al Gadban MM; Rembiesa B; Klein RL; Hannun YA; Bielawski J; Bielawska A
    J Lipid Res; 2010 Oct; 51(10):3074-87. PubMed ID: 20660127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
    Kaplowitz ET; Ferguson S; Guerra M; Laskin CA; Buyon JP; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Merrill JT; Katz P; Salmon JE
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):230-235. PubMed ID: 28480528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry.
    Sullards MC
    Methods Enzymol; 2000; 312():32-45. PubMed ID: 11070861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Lipoprotein Sphingolipids in Chronic Kidney Disease with and without Diabetes.
    Lopes-Virella MF; Hammad SM; Baker NL; Klein RL; Hunt KJ
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids/ceramides in subjects with obesity: lipidomics analysis.
    Madkour MI; Islam MT; Tippetts TS; Chowdhury KH; Lesniewski LA; Summers SA; Zeb F; Abdelrahim DN; AlKurd R; Khraiwesh HM; AbuShihab KH; AlBakri A; Obaideen K; Faris ME
    Sci Rep; 2023 Oct; 13(1):17322. PubMed ID: 37833312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic disparities among patients with systemic lupus erythematosus in South Carolina.
    Anderson E; Nietert PJ; Kamen DL; Gilkeson GS
    J Rheumatol; 2008 May; 35(5):819-25. PubMed ID: 18381790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.
    Allen PC; Roberts K; Rubio JE; Tiwari HK; Absher DM; Cooper SJ; Myers RM; Brown EE
    J Autoimmun; 2023 Sep; 139():103089. PubMed ID: 37506491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
    Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
    Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.
    Lyn-Cook BD; Xie C; Oates J; Treadwell E; Word B; Hammons G; Wiley K
    Mol Immunol; 2014 Sep; 61(1):38-43. PubMed ID: 24865418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus - Fulton and DeKalb Counties, Georgia, 2002-2016.
    Lim SS; Helmick CG; Bao G; Hootman J; Bayakly R; Gordon C; Drenkard C
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(18):419-422. PubMed ID: 31071073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.